Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Barski

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
EXCLI Journal|September 18, 2023
Bladder cancer course, four genetic high-risk variants, and histopathological findingsThura Kadhum, Silvia Selinski, Meinolf Blaszkewicz, et al.
Central European Journal of Urology|November 3, 2018
Desperate need for better management of Fournier's gangreneJennifer Kranz, Daniel Schlager, Petra Anheuser, et al.
International Journal of Surgery (London, England)|April 19, 2017
Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case seriesDimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
BJU International|June 26, 2024
Real-world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Anton P Kravchuk, Ralph M Wirtz, et al.
International Journal of Molecular Sciences|July 27, 2022
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene AssessmentThorsten H Ecke, Paula Carolin Voß, Thorsten Schlomm, et al.
Clinical Genitourinary Cancer|April 28, 2026
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine CytologyAnton Kravchuk, Julio Ruben Rodas Garzaro, Ralph Wirtz, et al.
Urology|December 3, 2024
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to CytologyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
Urologic Oncology|July 5, 2023
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter studyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
BJU International|December 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre datasetChristina J Meisl, Pierre I Karakiewicz, Roland Einarsson, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
EXCLI Journal|September 18, 2023
Bladder cancer course, four genetic high-risk variants, and histopathological findingsThura Kadhum, Silvia Selinski, Meinolf Blaszkewicz, et al.
Central European Journal of Urology|November 3, 2018
Desperate need for better management of Fournier's gangreneJennifer Kranz, Daniel Schlager, Petra Anheuser, et al.
International Journal of Surgery (London, England)|April 19, 2017
Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case seriesDimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
BJU International|June 26, 2024
Real-world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trialIngmar Wolff, Anton P Kravchuk, Ralph M Wirtz, et al.
International Journal of Molecular Sciences|July 27, 2022
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene AssessmentThorsten H Ecke, Paula Carolin Voß, Thorsten Schlomm, et al.
Clinical Genitourinary Cancer|April 28, 2026
Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine CytologyAnton Kravchuk, Julio Ruben Rodas Garzaro, Ralph Wirtz, et al.
Urology|December 3, 2024
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to CytologyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
Urologic Oncology|July 5, 2023
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter studyThorsten H Ecke, Christina J Meisl, Thorsten Schlomm, et al.
BJU International|December 20, 2021
Nomograms including the UBC<sup>®</sup> Rapid test to detect primary bladder cancer based on a multicentre datasetChristina J Meisl, Pierre I Karakiewicz, Roland Einarsson, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pageof 5